Atsuo Nakagawa, MD, PhD

Atsuo Nakagawa, MD, PhD is a contributing author on Psychiatrist.com. Atsuo Nakagawa has authored or co-authored 4 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2007 and 2017. Their work focuses on Depression (MDD) and Suicide.

Depression (MDD) Suicide

Frequent co-authors

Andrea Cipriani Corrado Barbui Hugh McGuire Rachel Churchill Toshiaki A. Furukawa Alessandra Signoretti Dai Mitsuda Daisuke Fujisawa

Original Research

CBT for Pharmacotherapy-Resistant Depression

February 28, 2017

Read a randomized control trial examining whether adding cognitive-behavioral therapy (CBT) for Pharmacotherapy-Resistant Depression improves outcomes.

Atsuo Nakagawa, Dai Mitsuda, Mitsuhiro Sado, et al

Original Research

Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression? A Systematic Review and Meta-Analysis

November 30, 2008

Corrado Barbui, Andrea Cipriani, Toshiaki A. Furukawa, et al

Original Research

Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major Depression: Systematic Review and Meta-Analysis

September 30, 2008

Corrado Barbui, Andrea Cipriani, Toshiaki A. Furukawa, et al

Original Research

Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003

June 15, 2007

Michael F. Grunebaum, Steven P. Ellis, Maria A. Oquendo, et al

Atsuo Nakagawa, MD, PhD

Frequent co-authors

CBT for Pharmacotherapy-Resistant Depression

Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression? A Systematic Review and Meta-Analysis

Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major Depression: Systematic Review and Meta-Analysis

Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003

ELSEWHERE:

FOLLOW US:

Atsuo Nakagawa, MD, PhD

Frequent co-authors

CBT for Pharmacotherapy-Resistant Depression

Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression? A Systematic Review and Meta-Analysis

Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major Depression: Systematic Review and Meta-Analysis

Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003

Live Webinar and Q&A With Dr Deligiannidis

Subscribe to readmore articles

Live Webinar
and Q&A With
Dr Deligiannidis

Subscribe to read
more articles